
Journal of Medicinal Chemistry p. 19 - 24 (1991)
Update date:2022-08-05
Topics: Structure-activity relationships
Alker
Campbell
Cross
The preparation of 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy) methyl]-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyrimidine (2) is described, and its potent calcium antagonist activity on rat aorta (IC50 = 4 x 10-9 M
View MoreContact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Nantong Auxin Electronic Technology Co., LTD
Contact:86-513-88760026
Address:NO.5-1, Aoxin Road, Haian Hi-tech Development Zone, Jiangsu Province, China
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Doi:10.1021/jo00067a015
(1993)Doi:10.1021/ma902849r
(2010)Doi:10.1007/BF00487438
(1990)Doi:10.1007/BF00497215
(1990)Doi:10.1016/S0040-4039(00)97490-2
(1990)Doi:10.1021/ol0602708
(2006)